# Arteaus Therapeutics, LLC — Form D/A

Arteaus Therapeutics, LLC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2012-07-24. The offering totals $18.0M, of which $15.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-07-24
- Form: D/A
- Accession: 0001526753-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $18.0M
- Amount sold: $15.6M
- Remaining: $2.4M
- Investors: 3
- Security types: equity
- Revenue range: Decline to Disclose

## Issuer

- Name: Arteaus Therapeutics, LLC
- CIK: 0001526753
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 25 FIRST STREET, CAMBRIDGE, MA, 02141
- Phone: 617-588-2600

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Jean-Francois Formela | Director | Cambridge, MA |
| David Grayzel | Director | Cambridge, MA |
| David Grayzel | Executive Officer | Cambridge, MA |
| Thomas Schuetz | Director | Cambridge, MA |
| Jean-Francois Fromela | Director | Cambridge, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2011-07-29](https://search.stillhousedata.com/formd/0001526753-11-000001) | D | $18.0M | $3.6M |

## More

- [CIK 1526753 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1526753&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001526753-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.